Acculi Labs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.14 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.20 M
- Revenue Growth 28.59%
- Profit Growth 61.15%
- Ebitda 57.36%
- Net Worth 4.59%
- Total Assets 471.97%
About Acculi Labs
Acculi Labs Private Limited (ALPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 May 2017 (Seven years and eight months 26 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.14 M.
The company currently has active open charges totaling ₹2.20 M.
Rupam Das, Moumita Das, and Akbar serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72900KA2017PTC103431
- Company No.
103431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2017
- Date of AGM
13 Feb 2023
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Acculi Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupam Das  | Director | 30-May-2017 | Current |
| Moumita Das | Director | 30-May-2017 | Current |
| Akbar | Director | 26-Sep-2020 | Current |
Financial Performance of Acculi Labs.
Acculi Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.59% increase. The company also saw a substantial improvement in profitability, with a 61.15% increase in profit. The company's net worth moved up by a moderate rise of 4.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acculi Labs?
In 2021, Acculi Labs had a public holding of 26.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Paio Investment Consultancy Private LimitedRupam Das is a mutual person
- Subhankar Sports Private Limited
Moumita Das is a mutual person
Charges (Loans)
₹2.20 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2021 | Others | ₹2.20 M | Open |
How Many Employees Work at Acculi Labs?
Acculi Labs has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acculi Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acculi Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
